✦ LIBER ✦

7059 POSTER Incidence and Outcomes of Brain and Meningeal Metastases (BMm) in Patients With Castration-resistant Prostate Cancer (CRPC) in the Era of Docetaxel (DOC)

✍ Scribed by Caffo, O.; Gernone, A.; Ortega, C.; Sava, T.; Cartenì, G.; Facchini, G.; Lo Re, G.; Bortolus, R.; Veccia, A.; Galligioni, E.

Book ID: 123058422
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 44 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)72010-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7050 POSTER Multiple Docetaxel (DOC) Re-

7050 POSTER Multiple Docetaxel (DOC) Re-challenges (ReC) in Castration-resistant Prostate Cancer (CRPC) Patients (pts) – Outcomes and Predictive Factors of Response

✍ Caffo, O.; Caldara, A.; Ferro, A.; Frisinghelli, M.; Murgia, V.; Soini, B.; Vald 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Impact Of Bone Metastases (Bm) On The Hu

Impact Of Bone Metastases (Bm) On The Humanistic Burden In Patients With Castration-Resistant Prostate Cancer (Crpc)

✍ Hechmati, G.; Arellano, J.; Haynes, I.; Worsfold, A.; Rider, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

7024 Phase Ib dose-finding trial of intr

7024 Phase Ib dose-finding trial of intravenous (i.v.) panobinostat (PAN) with docetaxel (DOC) and prednisone (PRED) in patients (pts) with castration resistant prostate cancer (CRPC)

✍ Vaishampayan, U.; Rathkopf, D.; Chi, K.N.; Hotte, S.; Vogelzang, N.; Alumkal, J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

P124 Long-term safety of radium-223 dich

P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study

✍ Nilsson, S; Schrader, A.J.; Kliment, J.; Solberg, A.; Franzén, L.; Bottomley, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Radium-223 Chloride Safety and Use of Ex

Radium-223 Chloride Safety and Use of External Beam Radiation Therapy (EBRT) in the Phase III Randomized Trial (ALSYMPCA) in Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastases

✍ Sandler, H.M.; Nilsson, S.; Parker, C.; Garcia-Vargas, J.; Staudacher, K.; Hoski 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 97 KB

714 PAIN AND QUALITY OF LIFE (QOL) ANALY

714 PAIN AND QUALITY OF LIFE (QOL) ANALYSES FROM THE PHASE 3 RANDOMIZED ALSYMPCA STUDY WITH RADIUM-223 DICHLORIDE (RA-223) IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS WITH BONE METASTASES

✍ Tomblyn, Michael; Nilsson, Sten; Vogelzang, Nicholas; Sartor, A. Oliver; Cislo, 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB